LOGIN  |  REGISTER
Cue Biopharma
Cue Biopharma

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

July 19, 2023 | Last Trade: US$10.83 0.16 -1.46

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
06/30/202396,250,954 

Total gross of voting rights: 96,250,954

 
 

Total net* of voting rights: 96,100,982

 

* Net total = total number of voting rights attached to shares – shares without voting rights = 96,250,954 –149,972= 96,100,982

Terns Pharmaceuticals

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page